Five prominent insider purchases totaling more than $8.3 million were disclosed on Friday, led by directors at Global Water Resources and AEON Biopharma. Directors at Global Water Resources Jonathan L. Levine and Andrew M. Cohn each acquired shares worth approximately $5.77 million and $1.23 million respectively on August 20, at $8.85 per share. The company’s common stock last traded at $8.88, giving it a market capitalization of $255 million.
AEON Biopharma director and 10% owner Timothy P. Lynch purchased 1.15 million Class A common shares on August 19 for about $243,455, at prices ranging from $0.1975 to $0.2164. Lynch’s direct and indirect holdings now total 6.5 million shares. The stock has declined 30% over the past week and is trading near its 52-week low of $0.18.
Universal Safety Products director Milton C. Ault III acquired stock worth $183,344 between August 20 and 21, at prices between $6.0667 and $6.37 per share. The stock surged 86% over the past week.
Elanco Animal Health director Lawrence Erik Kurzius bought 40,000 shares for approximately $935,920 on August 20, at prices between $23.385 and $23.40 per share. The stock has gained 35% over the past year and was last quoted at $23.98.
On the selling side, Cloudflare president and board co-chair Michelle Zatlyn disposed of 99,009 Class A shares worth about $28.3 million between August 19 and 21, under a 10b5-1 plan adopted in February. The stock fell 7% over the prior week but remains 65% higher than six months ago.
Illumina director Keith A. Meister sold 683,474 shares for $145.56 million between August 19 and 21, at prices between $202.37 and $220.13 per share. The stock is near its 52-week high and has risen 80% over the past year.
SOLV Energy’s largest shareholder, American Securities LLC, sold 7.94 million Class A shares for approximately $220.5 million at $27.77 per share on August 19. The stock is down 11% over the past week but remains undervalued relative to InvestingPro’s fair value estimate.
Advanced Micro Devices CTO Mark D. Papermaster sold 28,811 shares for $13.60 million on August 20 under a 10b5-1 plan adopted in November 2025. The stock has surged 189% over the past year and was last quoted at $473.21.
ACM Research CFO Mark McKechnie sold 55,199 shares for $4.26 million on August 20 under a 10b5-1 plan adopted in May 2026, while exercising options worth $935,828. The stock has gained 160% over the past year but remains 38% below its 52-week high of $127.19.
